Rhinase

Profounda is a privately held pharmaceutical company focused on developing and marketing niche healthcare products, most notably the Rhinase line of nasal care solutions. The company's flagship Rhinase products are formulated as steroid-free, dye-free nasal sprays and gels designed to alleviate nasal dryness and irritation using a dual-salt formulation. Beyond respiratory care, Profounda manages a portfolio that includes Impavido (miltefosine), an FDA-approved oral treatment for visceral, mucosal, and cutaneous leishmaniasis. The company emphasizes providing cost-effective, high-quality therapeutic options for underserved medical needs.